Botulinum toxin
Infectious agent:
Toxin produced by Clostridium botulinum, a spore forming obligate anaerobic bacillus. Three forms of botulims: 1) foodborne (the classic form), 2) wound, and 3) intestinal (infant and adult).
Incubation:
Neurologic symptoms of foodborne botulism appear within 12-36
hours, sometimes several days, after eating contaminated food.
The shorter the incubation period, the more severe the disease
and higher case-fatality rate.
Mode of transmission:
Ingestion of food with preformed toxin (foodborne botulism),
ingestion of botulism spores which then germinate and produce
toxin in the colon (intestinal botulism), contamination of wounds
by soil or gravel (wound botulism)
Period of communicability:
Despite excretion of C. botulinum toxin and organisms
at high levels in the feces of intestinal botulism patients
for weeks to months after illness onset, no instance of secondary
person to person transmission has been documented. Foodborne
botulism patients typically excrete the toxin and organisms
for shorter periods.
Clinical Symptoms:
Foodborne botulism: acute bilateral cranial nerve impairment
and descending weakness or paralysis. Visual difficulty (blurred
or double vision), dysphagia and dry mouth are often the first
complaints. Symptoms may extend to a symmetrical flaccid paralysis
in a paradoxically alert person. Vomiting and constipation or
diarrhea may be present initially. Fever is absent unless a
complicating infection occurs.
Wound botulism: the same clinical picture is seen after
the causative organism contaminates a wound in which anaerobic
conditions develop.
Intestinal (infant) botulism: illness begins with constipation,
followed by lethargy, listlessness, poor feeding, ptosis, difficulty
swallowing, loss of head control, hypotonia extending to generalized
weakness (the "floppy baby") and, in some cases, respiratory
insufficiency.
Pneumonic plague may be highly communicable under appropriate
climatic conditions; overcrowding facilitates transmission.
Prophylaxis if exposed:
Trivalent (type A, B and E) and monovalent (type E) antitoxin
available contact local public health unit.
Diagnosis:
Clinical basis, no specific laboratory findings and limited
diferential diagnosis. Intentional release suspected if number
of co-located cases present.
Precautions:
Standard precautions are recommended.
Source:
Control of Communicable
Diseases Manual, Chin 17th edition, 2000, and Biological
Agent Information Papers, United States Army Institute of Infectious
Diseases.
|